Secondary malignancies in non‐Hodgkin lymphoma survivors: 40 years of follow‐up assessed by treatment modality

BACKGROUND: Survivors of non‐Hodgkin lymphoma (NHL) have increased secondary malignancy (SM) risk. We quantified this risk by patient and treatment factors. METHODS: Standardized incidence ratios (SIR, observed‐to‐expected [O/E] ratio) were assessed in 142,637 NHL patients diagnosed from 1975 to 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Parsons, Matthew W., Rock, Calvin, Chipman, Jonathan J., Shah, Harsh R., Hu, Boyu, Stephens, Deborah M., Tao, Randa, Tward, Jonathan D., Gaffney, David K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939160/
https://www.ncbi.nlm.nih.gov/pubmed/36812123
http://dx.doi.org/10.1002/cam4.5139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939160/
https://www.ncbi.nlm.nih.gov/pubmed/36812123
http://dx.doi.org/10.1002/cam4.5139

Ejemplares similares